Pasithea Therapeutics Corp. - stock earnings
KTTA Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -3.6 million USD | ? USD |
| 2023Q2 | -3.8 million USD | ? USD |
| 2023Q1 | -275.1 million USD | ? USD |
| 2022Q4 | -3.9 million USD | 240712 USD |
| 2022Q3 | -5.3 million USD | 218608 USD |
| 2022Q2 | -1.8 million USD | 13581 USD |
| 2022Q1 | 41354 USD | 13658 USD |
| 2021Q4 | 630123 USD | 15062 USD |
| 2021Q3 | -1.5 million USD | ? USD |
| 2021Q2 | -727947 USD | ? USD |
| 2021Q1 | -549609 USD | ? USD |
| 2020Q3 | -13970 USD | ? USD |
KTTA Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -16.0 million USD | 486559 USD |
| 2022 | -13.1 million USD | 486559 USD |
| 2021 | -2.2 million USD | 15062 USD |
| 2020 | -40984 USD | ? USD |
KTTA
Price: $6.92
52 week price:
Earnings Per Share: -12.64 USD
P/E Ratio: -0.50
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 51500
Market Capitalization: 8.2 million